Bull
$10.73
Scenario price
$10.130
0.000 (0.00%)At close
Goldman Sachs BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company seeks to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien, first lien/last-out unitranche and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments. It may also originate covenant-lite loans, which are loans with fewer financial maintenance covenants than other obligations, or no financial maintenance covenants. In addition to investments in United States middle-market companies, it may invest a portion of its capital in opportunistic investments, such as in large United States companies, foreign companies, stressed or distressed debt, structured products or private equity. It invests in various sectors, including automobiles, chemicals and financial services. Its investment advisor is Goldman Sachs Asset Management, L.P.
Goldman Sachs BDC Inc is currently priced at $10.13, which is close to the analyst price target of $10 from Truist. The stock has a high RSI of 72.371, indicating it may be overbought in the short term. While the recent earnings report showed a non-GAAP net investment income of $0.37, beating estimates by $0.06, the downgrade by BofA to 'Underperform' raises concerns about future performance due to legacy assets impacting credit quality.
Truist
$10
2026-08-10
Truist
2026-08-10
Price Target
$10
BofA
$9
2026-07-09
BofA
2026-07-09
Price Target
$9
Truist
$9
2026-05-19
Truist
2026-05-19
Price Target
$9
BofA
$9
2026-03-09
BofA
2026-03-09
Price Target
$9
Truist
$10
2026-03-04
Truist
2026-03-04
Price Target
$10
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Goldman Sachs: Yen Intervention Effects Diminishing

Oklo Inc.: Merging Nuclear Energy with AI Demand

Goldman Sachs BDC Q2 Earnings Exceed Expectations

Goldman Sachs BDC Reports Q2 Financial Highlights

ARK Genomic Revolution ETF Underperforms
Goldman Sachs BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company seeks to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien, first lien/last-out unitranche and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments. It may also originate covenant-lite loans, which are loans with fewer financial maintenance covenants than other obligations, or no financial maintenance covenants. In addition to investments in United States middle-market companies, it may invest a portion of its capital in opportunistic investments, such as in large United States companies, foreign companies, stressed or distressed debt, structured products or private equity. It invests in various sectors, including automobiles, chemicals and financial services. Its investment advisor is Goldman Sachs Asset Management, L.P. It operates in the Financials sector.
Goldman Sachs BDC Inc is currently priced at $10.13, which is close to the analyst price target of $10 from Truist. The stock has a high RSI of 72.371, indicating it may be overbought in the short term. While the recent earnings report showed a non-GAAP net investment income of $0.37, beating estimates by $0.06, the downgrade by BofA to 'Underperform' raises concerns about future performance due to legacy assets impacting credit quality.
6 analysts cover GSBD: 1 rate it Buy, 4 Hold and 1 Sell. The average price target is 10.06.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.